
There is an urgent need to generate new drugs or improve existing ones in the pharmacology of mood zzso The zzso hormone zzso system is closely involved in the development and course of depression, and drugs targeting this system arguably offer hope to improve the current tools for drug treatment of zzso Recent clinical studies in depressed patients showed that zzso zzso improve clinical symptoms of anxiety and depression and reduce stress hormone release following zzso zzso These effects of zzso zzso were not associated with reduced zzso capacity of zzso cells because of zzso zzso abundance at the zzso level, which contrasts with zzso receptors in the zzso This is in accordance with previous studies showing that zzso injections into the mouse brain activate zzso pathways in a brain zzso manner pointing toward differences in signaling pathways beyond the zzso zzso We will highlight this and discuss how these brain zzso differences may offer opportunities for drug zzso An additional puzzle in the search of new targets for depression is the lack of bona fide animal models helping to discover the zzso that are not zzso zzso We recently developed a conditional mouse model that zzso zzso in a zzso fashion and permits to dissect precisely the contribution of different brain areas to the zzso zzso Recent findings obtained with this mouse model and its usefulness in the context of the zzso zzso changes in depression will be zzso 

